NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5205.44B
Enterprise Value 3225.15B
Trailing P/E 18.39
Forward P/E 115.81
PEG Ratio (5 yr expected) 12.19
Price/Sales (ttm)3.82
Price/Book (mrq)3.99
Enterprise Value/Revenue 34.18
Enterprise Value/EBITDA 613.32

Trading Information

Stock Price History

Beta (3Y Monthly) 0.55
52-Week Change 319.49%
S&P500 52-Week Change 31.11%
52 Week High 395.00
52 Week Low 372.73
50-Day Moving Average 391.18
200-Day Moving Average 385.32

Share Statistics

Avg Vol (3 month) 32.12M
Avg Vol (10 day) 31.49M
Shares Outstanding 52.29B
Float 2.15B
% Held by Insiders 10.00%
% Held by Institutions 111.69%
Shares Short (Jul 31, 2019) 43.08M
Short Ratio (Jul 31, 2019) 41.94
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 40.13%
Shares Short (prior month Jun 28, 2019) 43.78M

Dividends & Splits

Forward Annual Dividend Rate 42.83
Forward Annual Dividend Yield 43.17%
Trailing Annual Dividend Rate 32.89
Trailing Annual Dividend Yield 33.23%
5 Year Average Dividend Yield 43.26
Payout Ratio 496.07%
Dividend Date 3Mar 13, 2019
Ex-Dividend Date 4Mar 4, 2019
Last Split Factor (new per old) 21000/1116
Last Split Date 3Apr 9, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 21.15%
Operating Margin (ttm)21.78%

Management Effectiveness

Return on Assets (ttm)5.67%
Return on Equity (ttm)10.74%

Income Statement

Revenue (ttm)53.83B
Revenue Per Share (ttm)23.28
Quarterly Revenue Growth (yoy)3.20%
Gross Profit (ttm)36.08B
EBITDA 16.9B
Net Income Avi to Common (ttm)6.89B
Diluted EPS (ttm)4.87
Quarterly Earnings Growth (yoy)-12.50%

Balance Sheet

Total Cash (mrq)10.24B
Total Cash Per Share (mrq)4.47
Total Debt (mrq)30.27B
Total Debt/Equity (mrq)58.77
Current Ratio (mrq)0.94
Book Value Per Share (mrq)22.44

Cash Flow Statement

Operating Cash Flow (ttm)13.34B
Levered Free Cash Flow (ttm)15.19B